The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Open accessThe DOI matches its Crossref record; 120 of the 140 references it cites were found in a registry or an index; 9 of the 77 sources its claims cite were checked for support.
Abstract
OBJECTIVE: The objective of the study was to develop clinical practice guidelines for the diagnosis of Cushing's syndrome. PARTICIPANTS: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, five additional experts, a methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage the Task Force incorporated needed changes in response to written comments. CONCLUSIONS: After excluding exogenous glucocorticoid use, we recommend testing for Cushing's syndrome in patients with multiple and progressive features compatible with the syndrome, particularly those with a high discriminatory value, and patients with adrenal incidentaloma. We recommend initial use of one test with high diagnostic accuracy (urine cortisol, late night salivary cortisol, 1 mg overnight or 2 mg 48-h dexamethasone suppression test). We recommend that patients with an abnormal result see an endocrinologist and undergo a second test, either one of the above or, in some cases, a serum midnight cortisol or dexamethasone-CRH test. Patients with concordant abnormal results should undergo testing for the cause of Cushing's syndrome. Patients with concordant normal results should not undergo further evaluation. We recommend additional testing in patients with discordant results, normal responses suspected of cyclic hypercortisolism, or initially normal responses who accumulate additional features over time.
Overview
CoChat Summary
TL;DR
This Endocrine Society guideline recommends case detection for Cushing's syndrome only in selected high-risk groups, initial testing with one of four high-accuracy tests, and confirmatory second testing before cause-directed evaluation. It emphasizes excluding exogenous glucocorticoids first and notes that most recommendations rest on very low- to low-quality evidence.
Key findings
- Exclude exogenous glucocorticoid exposure before biochemical testing (1QQQQ); test patients with multiple and progressive features, unusual features for age, children with decreasing height percentile and increasing weight, or adrenal incidentaloma compatible with adenoma, and recommend against widespread testing in other groups.
- Initial testing should use one of: urine free cortisol (at least two measurements), late-night salivary cortisol (two measurements), 1-mg overnight dexamethasone suppression test, or 48-h 2 mg/d dexamethasone suppression test; recommend against random serum cortisol/plasma ACTH, urinary 17-ketosteroids, insulin tolerance test, loperamide test, and cause-directed tests for initial diagnosis.
- Reported test performance includes late-night salivary cortisol sensitivity 92–100% and specificity 93–100%; pediatric UFC sensitivity about 89%; 1-mg DST at a 1.8 µg/dL cutoff sensitivity >95% with specificity 80%, rising to >95% specificity at a 5 µg/dL threshold; LDDST sensitivity 96% and specificity 70%; dexamethasone-CRH sensitivity 98% and specificity 60%.
- Special-population recommendations: use UFC and avoid dexamethasone testing in pregnancy; avoid dexamethasone testing with enzyme-inducing antiepileptics; suggest 1-mg overnight DST rather than UFC in severe renal failure; suggest UFC or midnight salivary cortisol rather than DSTs in suspected cyclic Cushing's; suggest 1-mg DST or late-night cortisol rather than UFC in adrenal incidentaloma.
Methods
- A six-member Task Force appointed by The Endocrine Society's Clinical Guidelines Subcommittee, including a chair, five additional experts, a methodologist, and a medical writer, received no corporate funding or remuneration; consensus was guided by systematic reviews and discussions and approved sequentially by Society bodies and members.
- Recommendations used the GRADE approach: strong recommendations phrased “we recommend” with number 1, weak recommendations “we suggest” with number 2; evidence quality ranged from QEEE (very low) to QQQQ (high), informed by best available research evidence and systematic reviews/meta-analyses of test accuracy.
- The guideline presents evidence, values, and remarks linked to each recommendation; technical remarks often reflect the panel's unsystematic observations applied to a typical patient.
Limitations
- Stated: the majority of recommendations are based on very low- to low-quality evidence, with limited data linking diagnostic strategies to patient-important outcomes and no higher-quality direct evidence available.
- Stated: published data often come from larger tertiary referral centers and may be biased toward more diagnostically challenging cases, higher pretest probability, and greater disease severity, potentially giving an overly sanguine view of test performance in unselected populations.
- Evident from the text: this is a consensus guideline rather than a primary study, and some technical recommendations rest on unsystematic panel observations; data on treating mild/subclinical Cushing's syndrome and adrenal incidentaloma are described as limited and conflicting.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 37 Not checked · 33 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another study of 86 consecutive obese subjects referred to an endocrine clinic with diabetes mellitus, hypertension, and/or the polycystic ovary syndrome found a 5.8% incidence of Cushing's syndrome (35).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.3 Evidence
What the sources say
- Partly supportedcites [35] Ness-Abramof, 2002, Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese., Obes Res sourceExperimental — accuracy not yet measured
The Patients section describes 86 obese patients referred to an endocrine clinic, and the Results report five Cushing’s syndrome diagnoses—5/86, or approximately 5.8%, though the paper prints 5.7%. The copy does not say the patients were consecutive. It also reports that 51 had obesity alone, so diabetes, hypertension, and polycystic ovary disease do not describe the whole group. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The salivary glands express 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which converts the biologically active cortisol to inactive cortisone (75).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.2 Remarks for late-night salivary cortisol
What the sources say
- Supportedcites [75] Smith, 1996, Localization of 11β-hydroxysteroid dehydrogenase type II in human epithelial tissues., J Clin Endocrinol Metab source
The paper reports 11β-HSD2 in the ducts of human parotid and submandibular salivary glands (Abstract; Discussion, p. 3247). It describes the enzyme as inactivating glucocorticoids and discusses salivary cortisol-to-cortisone ratios (Introduction; Discussion, p. 3247), supporting the stated function. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Overall, the evidence in adults suggests that the accuracy of this test is similar to that of UFC (2).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.2 Evidence for late-night salivary cortisol
What the sources say
- Supportedcites [2] Elamin, 2008, Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses., J Clin Endocrinol Metab source
Table 3 (Conclusions; page unavailable) reports broadly similar pooled diagnostic likelihood ratios for midnight salivary cortisol and UFC. The Summary of findings notes that evidence for salivary cortisol is more limited, consistent with the citing sentence’s cautious wording. (LLM, conf=0.88)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“When the assay upper limit of normal is used as a criterion, the overall evidence supports the diagnostic accuracy of UFC in adults suspected of having Cushing's syndrome (2,51).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.1 Evidence for use of UFC
What the sources say
- Partly supportedcites [2] Elamin, 2008, Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses., J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The Summary of findings says UFC has substantial evidence supporting its use to detect Cushing’s syndrome, and the pooled results table reports diagnostic accuracy across 14 UFC studies. The Subgroup analyses section identifies an assay-upper-limit cutoff, but the reported UFC estimate is pooled across studies rather than shown specifically for that cutoff. The Conclusions also limit the apparent accuracy to referral practices enriched with patients with Cushing’s syndrome; performance in usual clinical practice remains unclear. Page numbers were not available in our copy. (LLM, conf=0.83)
- Supportedcites [51] Pecori Giraldi, 2007, Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series., J Clin Endocrinol Metab source
The UFC results (p. 2) report 91.2% specificity in Cushing’s syndrome suspects when values above the assay’s reference range were considered abnormal. The Discussion (p. 5) identifies that threshold as the assay’s upper limit of normal and describes UFC as having superior diagnostic performance. The study assessed specificity, rather than diagnostic accuracy across all measures. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The four recommended tests have acceptable diagnostic accuracy when the suggested cutoff points are used (2,30).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4 Evidence
What the sources say
- Partly supportedcites [2] Elamin, 2008, Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses., J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The Conclusions state that commonly used tests appear highly accurate in referral practices with samples enriched for Cushing’s syndrome, but that their performance in usual clinical practice is unclear. The Data extraction section says the review used cutoffs chosen by the primary studies, selecting those with the best performance when several were available; it does not establish accuracy specifically at the suggested cutoff points. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [30] Batista, 2007, Diagnostic tests for children who are referred for the investigation of Cushing syndrome, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
48 more claims · 3 with their cited sources checked
Create a free account to see all 82 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, accurate serum cortisol measurement is essential for the correct diagnosis and management of adrenal pathologies.”
From Serum cortisol: an up-to-date assessment of routine assay performance (2016) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the reliability of almost all markers of HPA axis activity, particularly ACTH and 24-h urinary free cortisol (UFC), is low (3,14,23)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, UFC should not be considered an adequate screening test for SH and should be used in combination with other tests or in specific populations (1,14).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some authors have proposed higher (3 or 8 mg) dexamethasone doses (40,46,54,56), which however did not show a better performance (14,23,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measured
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.2 Evidence
“biochemical hypercortisolism is present in a large fraction (up to 10%).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.2 Evidence
“Libe et al. (32) reported 18%; Terzolo et al. (21) quoted 5-20%, depending on referral bias and diagnostic tests and criteria.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > Subsequent evaluation
“3.9.1 We suggest the additional use of the dexamethasone-CRH test or the midnight serum cortisol test in specific situations (Fig. 1, 1QEEE).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > METHOD OF DEVELOPMENT OF EVIDENCE-BASED RECOMMENDATIONS
“strong recommendations use the phrase "we recommend" and the number 1, and weak recommendations use the phrase "we suggest" and the number 2.”
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“with expertise in development and implementation of evidencebased guidelines (1).”
BackgroundCushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851 · cited 1×
“6 yr, and in 1952 a 5-yr survival of just 50%, with most deaths caused by vascular (myocardial infarction, cerebrovascular accident) or infectious complications (11, 12).”
BackgroundThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Self-citationGold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Self-citationThe natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763 · cited 1×
“6 yr, and in 1952 a 5-yr survival of just 50%, with most deaths caused by vascular (myocardial infarction, cerebrovascular accident) or infectious complications (11, 12).”
BackgroundTESTS OF PITUITARY-ADRENAL SUPPRESSIBILITY IN THE DIAGNOSIS OF CUSHING'S SYNDROME*
LIDDLE, G. W. (1960) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-20-12-1539 · Cited by 735
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730 · cited 1×
“These data are consistent with the increased cardiovascular mortality and morbidity reported in patients with iatrogenic Cushing’s syndrome secondary to the chronic use of synthetic corticosteroids (15).”
ResultMeasurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726 · cited 1×
“are associated with decreased serum cortisol values (39, 46).”
BackgroundMorbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622 · cited 2×
“0-fold, compared with the general population (4, 5).”
BackgroundIncidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619 · cited 6×
“Because some patients with Cushing’s disease demonstrate suppressibility to dexamethasone, use of this diagnostic criterion J Clin Endocrinol Metab, May 2008, 93(5):1526–1540 jcem.”
BackgroundInfluentialOMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562 · cited 1×
“5–1% prevalence of Cushing’s syndrome (36, 37).”
Characterization of the normal temporal pattern of plasma corticosteroid levels.
KRIEGER, D. T., ALLEN, W., RIZZO, F., & KRIEGER, H. P. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-2-266 · Cited by 549 · cited 1×
“2 Evidence for late-night salivary cortisol In healthy individuals with stable conventional sleep-wake cycles, the level of serum cortisol begins to rise at 0300–0400 h, reaches a peak at 0700–0900 h, and then falls for the rest of the day to very low levels when the person is unstressed and asleep at midnight (55).”
BackgroundIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Colao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450 · cited 3×
“Because markers of cardiovascular risk remain abnormal for up to 5 yr after surgery, further studies are needed to assess long-term SMR (14).”
BackgroundInfluentialThe hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449 · cited 1×
“Furthermore, suppression of serum and urinary cortisol by dexamethasone is blunted in pregnancy (105).”
BackgroundSelf-citationCushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou, M. A., Mastorakos, G., Oldfield, E. H., Gomez, M. T., Doppman, J. L., Cutler, G. B., Nieman, L. K., & Chrousos, G. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311002 · Cited by 430 · cited 2×
“For patients weighing less than 40 kg, the dose is adjusted to 30 g/kg d (in divided doses) (87).”
BackgroundSelf-citationAnderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403 · cited 1×
“5–1% prevalence of Cushing’s syndrome (36, 37).”
Cushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393 · cited 3×
“5 Evidence The diagnostic accuracy of various other tests previously advocated for the diagnosis of Cushing’s syndrome (urinary 17-ketosteroids, 1600 h or other random cortisol levels, and the insulin tolerance test) is too low to recommend them for testing (49).”
BackgroundSalivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
LAUDAT, M. H., CERDAS, S., FOURNIER, C., GUIBAN, D., GUILHAUME, B., & LUTON, J. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-343 · Cited by 393
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390 · cited 1×
“myopathy, plethora, red striae, easy bruising, and thin skin in the young) are present (6, 8).”
BackgroundMaternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy
Carr, B. R., Parker, C. R., Madden, J. D., MacDonald, P. C., & Porter, J. C. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90318-5 · Cited by 370
The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States
Newell-Price, J. D. C. (1998) · Endocrine Reviews · doi:10.1210/er.19.5.647 · Cited by 360
Self-citationCushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
Lindsay, J. R., Jonklaas, J., Oldfield, E. H., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2361 · Cited by 343 · cited 1×
“Whereas loss of circadian variation is characteristic of Cushing’s syndrome, diagnostic thresholds for evening serum or salivary cortisol in pregnant patients are not known (103, 104).”
BackgroundSelf-citationDiagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336 · cited 1×
“A widely cited normal response is a serum cortisol less than 5 g/dl ( 140 nmol/liter) (7, 80).”
BackgroundSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Self-citationOccult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
The relationship between smoking status and cortisol secretion.
Badrick, E., Kirschbaum, C., & Kumari, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2155 · Cited by 284 · cited 1×
“Patients who smoke cigarettes also have been shown to have higher late-night salivary cortisol measurements than do nonsmokers (76).”
BackgroundNighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020534 · Cited by 241
Self-citationBourdeau, I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1949 · Cited by 239
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Self-citationA single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell‐Price, J., Trainer, P., Perry, L., Wass, J., Grossman, A., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 229 · cited 3×
“g/dl ( 50 nmol/liter) had high sensitivity (100%) for the diagnosis of Cushing’s syndrome (96).”
BackgroundInfluentialSelf-citationSalivary cortisol reflects serum cortisol: analysis of circadian profiles.
Dorn, L. D., Lucke, J. F., Loucks, T. L., & Berga, S. L. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780480954 · Cited by 228
Accuracy of Diagnostic Tests for Cushing’s Syndrome: A Systematic Review and Metaanalyses
Elamin, M. B., Murad, M. H., Mullan, R., Erickson, D., Harris, K., Nadeem, S., Ennis, R., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0139 · Cited by 222 · cited 15×
“Overall, the evidence in adults indicates that in studies with low prevalence of Cushing’s syndrome this test has similar performance as the others recommended for initial testing (2).”
BackgroundMethodResultInfluentialSelf-citationLong-term follow-up study of patients with adrenal incidentalomas.
Libe, R., Dall'Asta, C., Barbetta, L., Baccarelli, A., Beck-Peccoz, P., & Ambrosi, B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470489 · Cited by 215
Nilsson, I. M., & Holmberg, L. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91962-x · Cited by 212
Lindsay, J. R., Nansel, T., Baid, S., Gumowski, J., & Nieman, L. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1058 · Cited by 210 · cited 1×
“Additionally, quality of life improves after surgical treatment but remains below that of age- and gendermatched subjects for up to 15 yr (18).”
BackgroundSelf-citationYanovski, J. A. (1993) · JAMA · doi:10.1001/jama.1993.03500170062035 · Cited by 205 · cited 2×
“4 g/dl)], the sensitivity was 90% in another study (9).”
BackgroundMEIKLE, A. W. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb00733.x · Cited by 201
Papanicolaou, D. A., Yanovski, J. A., Cutler, G. B., Chrousos, G. P., & Nieman, L. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4733 · Cited by 201
Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320069009 · Cited by 201 · cited 1×
“It is important to note that the circadian rhythm is blunted in many patients with depressive illness and in shift workers (69, 70) and may be absent in the critically ill (71).”
BackgroundKivlighan, K. T., Granger, D. A., Schwartz, E. B., Nelson, V., Curran, M., & Shirtcliff, E. A. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.01.006 · Cited by 195 · cited 1×
“(77) reported that minor to moderate blood leakage as a result of vigorous tooth brushing had no effect on salivary cortisol values, the possible effect of gingivitis or oral sores or injury is not known.”
BackgroundLate-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194 · cited 1×
“Finally, stress immediately before the collection also may increase salivary cortisol physiologically; therefore, ideally, samples should be collected on a quiet evening at home (64).”
BackgroundSelf-citationWood, P. J., Barth, J. H., Freedman, D. B., Perry, L., & Sheridan, B. (1997) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329703400302 · Cited by 190 · cited 1×
“8 g/dl (50 nmol/liter) to achieve sensitivity rates of greater than 95% (83).”
BackgroundSarlis, N. J., Chanock, S. J., & Nieman, L. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6294 · Cited by 186 · cited 1×
“Indirect evidence supporting the need for intervention includes the finding that the risk of infection is lower in patients with mild to moderate, compared with severe, hypercortisolism (19).”
BackgroundSelf-citationBone mineral density and bone turnover before and after surgical cure of Cushing's syndrome
Hermus, A. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2859 · Cited by 185 · cited 1×
“Bone mineral density and cognitive dysfunction improve after successful surgical treatment of Cushing’s syndrome but do not normalize in all patients (16, 17).”
BackgroundPutignano, P., Toja, P., Dubini, A., Giraldi, F. P., Corsello, S. M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030312 · Cited by 182 · cited 1×
“3–12 g/dl had 90– 92% sensitivity with specificity of 96% (63, 101).”
BackgroundMidnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
Yaneva, M., Mosnier-Pudar, H., Dugué, M.-A., Grabar, S., Fulla, Y., & Bertagna, X. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031790 · Cited by 179
Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.
Liu, H., Bravata, D. M., Cabaccan, J., Raff, H., & Ryzen, E. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02395.x · Cited by 178 · cited 1×
“(72) reported that 20% of all participants and 40% of diabetic hypertensive subjects had at least one elevated late-night salivary cortisol measurement.”
BackgroundViardot, A., Huber, P., Puder, J. J., Zulewski, H., Keller, U., & Müller, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2264 · Cited by 172
Diagnostic tests for children who are referred for the investigation of Cushing syndrome
Batista, D. L., Riar, J., Keil, M., & Stratakis, C. A. (2007) · Pediatrics · doi:10.1542/peds.2006-2402 · Cited by 165 · cited 3×
“Although the probability of Cushing’s syndrome has not been evaluated in a large number of children, clinical experience suggests that the specificity of these clinical features for the diagnosis is also very high (30).”
BackgroundMethodThe low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome
Findling, J. W., Raff, H., & Aron, D. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030207 · Cited by 165 · cited 1×
“misclassified up to 15% of such patients as negative (81, 82).”
BackgroundSelf-citationSubclinical hypercortisolism among outpatients referred for osteoporosis.
Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162
Saliva collection method affects predictability of serum cortisol.
Poll, E.-M., Kreitschmann-Andermahr, I., Langejuergen, Y., Stanzel, S., Gilsbach, J. M., Gressner, A., & Yagmur, E. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.03.009 · Cited by 162 · cited 2×
“Reports show good correlation between salivary and simultaneous serum cortisol values in healthy volunteers (73, 74).”
BackgroundCyclic Cushing’s syndrome: a clinical challenge
Meinardi, J. R., Wolffenbuttel, B. H. R., & Dullaart, R. P. F. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0262 · Cited by 161 · cited 2×
“Similarly, the recommendation to retest patients with suspected cyclic Cushing’s syndrome comes from the recognition that these individuals may have normal test results when the disorder is quiescent (93).”
BackgroundCastro, M., Elias, P. C. L., Quidute, A. R. P., Halah, F. P. B., & Moreira, A. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5521 · Cited by 151
Pituitary-adrenal function in severe depressive illness.
Butler, P. W. P., & Besser, G. M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91927-2 · Cited by 147 · cited 1×
“It is important to note that the circadian rhythm is blunted in many patients with depressive illness and in shift workers (69, 70) and may be absent in the critically ill (71).”
BackgroundLocalization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues.
Smith, R. E., Maguire, J. A., Stein-Oakley, A. N., Sasano, H., Takahashi, K., Fukushima, K., & Krozowski, Z. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784076 · Cited by 146 · cited 1×
“The salivary glands express 11 -hydroxysteroid dehydrogenase type 2 (11 -HSD2), which converts the biologically active cortisol to inactive cortisone (75).”
BackgroundPapanicolaou, D., Yanovski, J., Cutler, G., Chrousos, G., & Nieman, L. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1016/s0248-8663(98)80399-8 · Cited by 146
Self-citationBaid, S. K., Sinaii, N., Wade, M., Rubino, D., & Nieman, L. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2861 · Cited by 144 · cited 3×
“The best-validated assays used in the United States to measure salivary cortisol are an ELISA and an assay performed by LC-MS/MS (28).”
BackgroundMethodInfluentialSelf-citationPecori Giraldi, F., Pivonello, R., Ambrogio, A. G., De Martino, M. C., De Martin, M., Scacchi, M., Colao, A., Toja, P. M., Lombardi, G., & Cavagnini, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02717.x · Cited by 141 · cited 5×
“8 g/dl cutoff, the sensitivity is high with specificity rates of 80%; specificity increases to greater than 95% if the diagnostic threshold is raised to 5 g/dl (140 nmol/liter) (7).”
BackgroundInfluentialKlose, M., Lange, M., Rasmussen, A. K., Skakkebæk, N. E., Hilsted, L., Haug, E., Andersen, M., & Feldt-Rasmussen, U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1791 · Cited by 140
Samaras, K., Pett, S., Gowers, A., McMurchie, M., & Cooper, D. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0036 · Cited by 133 · cited 1×
“depends on the potency of the preparation used, its dose, the route and duration of its administration, and whether concomitant medications prolong its half-life (27).”
BackgroundQureshi, A. C., Bahri, A., Breen, L. A., Barnes, S. C., Powrie, J. K., Thomas, S. M., & Carroll, P. V. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02784.x · Cited by 133
Papanicolaou, D. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1163 · Cited by 130
Lin, C.-L., Wu, T.-J., Machacek, D. A., Jiang, N.-S., & Kao, P. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3687 · Cited by 129 · cited 1×
“may be as low as 40% of the value measured by RIA (42, 43).”
BackgroundKidambi, S., Raff, H., & Findling, J. W. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0424 · Cited by 129 · cited 1×
“Finally, it may be normal in some patients with mild Cushing’s syndrome, in whom salivary cortisol may be more useful (54).”
BackgroundSelf-citationde Castro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.878 · Cited by 126
Adrenal incidentaloma—follow-up results from a Swedish prospective study.
Bülow, B., Jansson, S., Juhlin, C., Steen, L., Thorén, M., Wahrenberg, H., Valdemarsson, S., Wängberg, B., Ahréen, B., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02110 · Cited by 124 · cited 1×
“(31) reported 2% prevalence of Cushing’s syndrome; Libe et al.”
BackgroundPecori Giraldi, F., Ambrogio, A. G., De Martin, M., Fatti, L. M., Scacchi, M., & Cavagnini, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0596 · Cited by 121 · cited 1×
“When the assay upper limit of normal is used as a criterion, the overall evidence supports the diagnostic accuracy of UFC in adults suspected of having Cushing’s syndrome (2, 51).”
MethodFinal stature in patients with endogenous Cushing's syndrome
Magiakou, M. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1082 · Cited by 119 · cited 1×
“Final stature in patients with endogenous Cushing’s syndrome was reported to be disappointing (26), but more recent data showed that most patients reach a final height within their predicted parental target range (24).”
BackgroundSalivary cortisol for screening of Cushing's syndrome in children.
Martinelli, C. E., Sader, S. L., Oliveira, E. B., Daneluzzi, J. C., & Moreira, A. C. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00749.x · Cited by 114 · cited 1×
“2%) for Cushing’s syndrome in this setting (68).”
BackgroundEndogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113 · cited 1×
“In general, patients with Cushing’s disease show an increase in ACTH, but those with other causes of Cushing’s syndrome or those without Cushing’s syndrome do not respond (7, 22, 102).”
BackgroundProbability theory in the diagnosis of Cushing's syndrome.
NUGENT, C. A., WARNER, H. R., DUNN, J. T., & TYLER, F. H. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-7-621 · Cited by 112 · cited 1×
“myopathy, plethora, red striae, easy bruising, and thin skin in the young) are present (6, 8).”
BackgroundHigh fluid intake increases urine free cortisol excretion in normal subjects.
Mericq, M. V., & Cutler, G. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4555 · Cited by 111
WALLACE, E. Z., ROSMAN, P., TOSHAV, N., SACERDOTE, A., & BALTHAZAR, A. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-46 · Cited by 107 · cited 3×
“Although the cortisol circadian rhythm was present in one study, neither serum nor salivary midnight cortisol concentrations have been reported in this population (106).”
BackgroundMoro, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3569 · Cited by 105 · cited 1×
“In general, patients with Cushing’s disease show an increase in ACTH, but those with other causes of Cushing’s syndrome or those without Cushing’s syndrome do not respond (7, 22, 102).”
BackgroundMann, M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.15.1651 · Cited by 101
Yanovski, J. A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.348 · Cited by 101 · cited 1×
“The initial report of this strategy showed high diagnostic accuracy (92, 94).”
BackgroundSelf-citationDetermination of urinary free cortisol by HPLC
Turpeinen, U., Markkanen, H., Välimäki, M., & Stenman, U.-H. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1386 · Cited by 99
Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment.
Chan, K. C. A., Lit, L. C. W., Law, E. L. K., Tai, M. H. L., Yung, C. U., Chan, M. H. M., & Lam, C. W. K. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.029934 · Cited by 99 · cited 1×
“A falsely low UFC can occur when creatinine clearance falls less than 60 ml/min, and UFC levels fall linearly with more severe renal failure (53).”
BackgroundLin, C.-L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.151 · Cited by 98
THE OVERNIGHT DEXAMETHASONE TEST IS A WORTHWHILE SCREENING PROCEDURE
CRONIN, C., IGOE, D., DUFFY, M. J., CUNNINGHAM, S. K., & MCKENNA, T. J. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00462.x · Cited by 94 · cited 1×
“2 g/dl (100–200 nmol/liter) when measured by modern RIA (79).”
MethodRoss, R. J. M., Miell, J. P., Holly, J. M. P., Maheshwari, H., Norman, M., Abdulla, A. F., & Buchanan, C. R. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03549.x · Cited by 93 · cited 1×
“It is important to note that the circadian rhythm is blunted in many patients with depressive illness and in shift workers (69, 70) and may be absent in the critically ill (71).”
BackgroundSalivary cortisol measurement—a reliable method for the diagnosis of Cushing's syndrome.
Trilck, M., Flitsch, J., Lüdecke, D., Jung, R., & Petersenn, S. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-837667 · Cited by 93
Mann, M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360053005 · Cited by 93
Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus
Reimondo, G., Pia, A., Allasino, B., Tassone, F., Bovio, S., Borretta, G., Angeli, A., & Terzolo, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02865.x · Cited by 89 · cited 1×
“In another recent report, one of 99 patients with newly diagnosed diabetes mellitus had surgically proven Cushing’s disease (34).”
BackgroundFinal adult height and body mass index after cure of paediatric Cushing's disease
Davies, J. H., Storr, H. L., Davies, K., Monson, J. P., Besser, G. M., Afshar, F., Plowman, P. N., Grossman, A. B., & Savage, M. O. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02244.x · Cited by 88 · cited 2×
“Although there are no formal controlled studies of consequences of cure in pediatric Cushing’s syndrome, improvements in growth and body composition after treatment are reported in both patients with adrenal and those with pituitary causes (24, 25).”
BackgroundSelf-citationSarlis, N. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.42 · Cited by 87
“Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients
Mitchell, I. C., Auchus, R. J., Juneja, K., Chang, A. Y., Holt, S. A., Snyder, W. H., & Nwariaku, F. E. (2007) · Surgery · doi:10.1016/j.surg.2007.10.001 · Cited by 84
Subclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80
NIEMAN, L. K., CUTLER, G. B., OLDFIELD, E. H., LORIAUX, D. L., & CHROUSOS, G. P. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-165 · Cited by 78 · cited 5×
“It is thought that higher brain centers stimulate CRH release in these conditions, with T H E E N D O C R I N E S O C I E T Y ' S C L I N I C A L G U I D E L I N E S”
BackgroundInfluentialSelf-citationEvaluation of the Hypothalamic Hypophyseal Adrenal Axis in Patients Receiving Long-term Hemodialysis
Ramírez, G. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.8.1448 · Cited by 76 · cited 1×
“Responses to administration of 3 and 8 mg dexamethasone were normal in some but not all patients (106, 108).”
BackgroundMartin, N. M., Dhillo, W. S., Banerjee, A., Abdulali, A., Jayasena, C. N., Donaldson, M., Todd, J. F., & Meeran, K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2143 · Cited by 71
Subclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 69
Reimondo, G., Allasino, B., Bovio, S., Paccotti, P., Angeli, A., & Terzolo, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02042 · Cited by 68 · cited 1×
“3–12 g/dl had 90– 92% sensitivity with specificity of 96% (63, 101).”
BackgroundKennedy, L., Atkinson, A. B., Johnston, H., Sheridan, B., & Hadden, D. R. (1984) · BMJ · doi:10.1136/bmj.289.6453.1188 · Cited by 67
Görges, R., Knappe, G., Gerl, H., Ventz, M., & Stahl, F. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343551 · Cited by 66 · cited 1×
“misclassified up to 15% of such patients as negative (81, 82).”
BackgroundGatta, B., Chabre, O., Cortet, C., Martinie, M., Corcuff, J.-B., Roger, P., & Tabarin, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2829 · Cited by 63
Meikle, A. W., Findling, J., Kushnir, M. M., Rockwood, A. L., Nelson, G. J., & Terry, A. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030234 · Cited by 63
Self-citationErickson, D., Natt, N., Nippoldt, T., Young, W. F., Carpenter, P. C., Petterson, T., & Christianson, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2662 · Cited by 60
Circadian rhythm of serum cortisol in Cushing's disease.
GLASS, A. R., ZAVADIL, A. P., HALBERG, F., CORNELISSEN, G., & SCHAAF, M. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-161 · Cited by 59 · cited 1×
“The loss of circadian rhythm with absence of a late-night cortisol nadir is a consistent biochemical abnormality in patients with Cushing’s syndrome (56, 57).”
BackgroundOvernight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness‐Abramof, R., Nabriski, D., Apovian, C. M., Niven, M., Weiss, E., Shapiro, M. S., & Shenkman, L. (2002) · Obesity Research · doi:10.1038/oby.2002.166 · Cited by 58 · cited 1×
“8% incidence of Cushing’s syndrome (35).”
Steroid analysis in saliva for the assessment of endocrine function.
Read, G. F., Walker, R. F., Wilson, D. W., & Griffiths, K. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34300.x · Cited by 57 · cited 1×
“Furthermore, an increase in blood cortisol is reflected by a change in the salivary cortisol concentration within a few minutes (58).”
BackgroundSalivary cortisol for the evaluation of Cushing's syndrome.
Luthold, W. W., Marcondes, J. A. M., & Wajchenberg, B. L. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90232-3 · Cited by 56
Nickelsen, T., Lissner, W., & Schöffling, K. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1210910 · Cited by 55 · cited 2×
“As noted above, false-positive rates for the overnight DST are seen in 50% of women taking the oral contraceptive pill because of increased CBG levels (44).”
BackgroundStorr, H. L., Mitchell, H., Swords, F. M., Main, K. M., Hindmarsh, P. C., Betts, P. R., Shaw, N. J., Johnston, D. I., Clark, A. J. L., Reznek, R. H., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02124.x · Cited by 50 · cited 1×
“Although there are no formal controlled studies of consequences of cure in pediatric Cushing’s syndrome, improvements in growth and body composition after treatment are reported in both patients with adrenal and those with pituitary causes (24, 25).”
BackgroundSelf-citationWORKMAN, R. J., VAUGHN, W. K., & STONE, W. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-741 · Cited by 47
REFETOFF, S., VAN CAUTER, E., FANG, V. S., LADERMAN, C., GRAYBEAL, M. L., & LANDAU, R. L. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-527 · Cited by 46 · cited 1×
“The loss of circadian rhythm with absence of a late-night cortisol nadir is a consistent biochemical abnormality in patients with Cushing’s syndrome (56, 57).”
BackgroundAssessment of Adrenocortical Function
Melby, J. C. (1971) · New England Journal of Medicine · doi:10.1056/nejm197109232851306 · Cited by 45 · cited 1×
“Since the 1970s, experts have advocated the use of UFC for making the diagnosis of Cushing’s syndrome (49, 50).”
BackgroundPseudohypercortisoluria: Spurious Elevation of Urinary Cortisol due to Carbamazepine
Findling, J. W., Pinkstaff, S. M., Shaker, J. L., Raff, H., & Nelson, J. C. (1998) · The Endocrinologist · doi:10.1097/00019616-199803000-00001 · Cited by 40
Self-citationAbnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.
Kyriazopoulou, V. E., & Vagenakis, A. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619024 · Cited by 40 · cited 1×
“Drugs such as phenytoin, phenobarbitone, carbamazepine, rifampicin, and alcohol induce hepatic enzymatic clearance of dexamethasone, mediated through CYP 3A4, thereby reducing the plasma dexamethasone concentrations (Table 3) (47).”
BackgroundScreening for Cushing’s syndrome in obese women with and without polycystic ovary syndrome
Putignano, P., Bertolini, M., Losa, M., & Cavagnini, F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345217 · Cited by 35 · cited 1×
“However, when applied to an obese cohort, the specificity was only 83% (100).”
MethodDexamethasone Suppression Test in Recently Detoxified Alcoholics: Clinical Implications
KHAN, A., CIRAULO, D. A., NELSON, W. H., BECKER, J. T., NIES, A., & JAFFE, J. H. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198404020-00006 · Cited by 28 · cited 1×
“Previous studies using various doses of dexamethasone and differing criteria for suppression suggest that at least 2 wk of abstinence from alcohol are needed to reduce the false-positive rate (84).”
MethodCarbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome
Ronald, C. W., Chan, W. B., So, W. Y., Tong, P. C. Y., Chan, J. C. N., & Chow, C. C. (2005) · BMJ · doi:10.1136/bmj.330.7486.299 · Cited by 28 · cited 2×
“Switching to nonenzyme-inducing medication may correct this situation, but an alternative and more practical approach is to use another test, such as assessment of midnight salivary or serum cortisol, to exclude Cushing’s syndrome in these patients (97).”
BackgroundMethodNieman, L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1289 · Cited by 24 · cited 1×
“In 59 patients with Cushing’s syndrome, sensitivity was 96% for the LDDST (91).”
BackgroundSelf-citationOğuz, Y., Öktenli, Ç., Özata, M., Ozgurtas, T., Sanısoğlu, Y., Yenicesu, M., Vural, A., Bulucu, F., & Kocar, I. H. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347016 · Cited by 19
Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy
Kyriazopoulou, V. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.315 · Cited by 14
Pikkarainen, L., Alfthan, H. V., Markkanen, H. M., & Sane, T. (2002) · PubMed · Cited by 13
Kennedy, L., Hadden, D., Atkinson, B., et al. (1985) · BMJ · doi:10.1136/bmj.290.6462.158-c
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
“Increased late night salivary cortisol Dexamethasone suppression tests [118]”
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
“Cushing’s syndrome Many of the signs and symptoms of PCOS can overlap with Cushing’s (ie, striae, obesity, dorsocervical fat (ie, buffalo hump, glucose intolerance); however, Cushing’s is more likely to be present when a large number of signs and symptoms, especially those with high discriminatory index (eg, myopathy,…”
Background
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M.
- Affiliations
- National Institutes of Health (US)
- Massachusetts General Hospital (US)
- Medical College of Wisconsin (US)
- University of Sheffield (GB)
- Queen Mary University of London (GB)
- University of Birmingham (GB)
- Mayo Clinic (V.M.M.), Rochester, Minnesota 55905
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-05-01
- Volume
- 93
- Issue
- 5
- Pages
- 1526-1540
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2386281
- OpenAlex
- W1990995386
- Cited by
- 2,718
- References
- 140
- Citations by year
- 2026: 159 · 2025: 173 · 2024: 173 · 2023: 148 · 2022: 212 · 2021: 199 · 2020: 195 · 2019: 165 · 2018: 150 · 2017: 148 · 2016: 158 · 2015: 156 · 2014: 134 · 2013: 139 · 2012: 114
- FWCI
- 70.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- European Society of Endocrinology
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Z01HD008833)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, diagnosis, hypercortisolism, adrenal incidentaloma, dexamethasone suppression test, late-night salivary cortisol, urine cortisol
- MeSH terms
- Cushing Syndrome, Dexamethasone, Humans, Hydrocortisone, Saliva, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.